JHOP Articles

Case Reports, Myelofibrosis, Dose Escalation/Reduction

Pacritinib Therapy in a Patient With End-Stage Renal Disease in the Setting of Cytopenic Myelofibrosis

Alexandra Roach, MD; Hayley Heers, PharmD, BCPS, BCOP; Vishangi Dave, MD; Naveen Pemmaraju, MD; Matthew Ulrickson, MD

Original Research, Adverse Events, Multiple Myeloma, Immunotherapy, Thromboembolism

Assessment of Appropriate Anticoagulation in Patients With Multiple Myeloma—A Health-System Specialty Pharmacy Retrospective Evaluation

Addie Planas, PharmD, CSP, CPh; Brittany Alvarez, PharmD, MBA; Beatriz Jimenez Cadilla, PharmD, BCACP; Karina Delgado, PharmD, MBA, BCPS; Jacqualine Igwe, PharmD, BCPS, et al.

HOPA Corner, Immunotherapy

Advancing Merkel-Cell Carcinoma Treatment With Immunotherapy

Voices From ASCO 2025

Advancing Treatments for Prostate and Bladder Cancers and Ensuring Equitable Access to Care: An Interview with Dr. Walter Stadler

Online First

Original Research, Thromboembolism, Gastrointestinal Cancers

Evaluation of Bleeding Risk With Apixaban Versus Rivaroxaban in Patients With Gastrointestinal Cancer

Parker Gundersen, PharmD, MBA, BCOP; Alexa Basilio, PharmD, BCOP; Amber Draper, PharmD, BCOP; Marley Watson, PharmD, BCOP; Emily Tiao, PharmD, BCOP, et al.

Online First

Case Reports, Adverse Events, Immunotherapy, Infusion Issues, Monoclonal Antibodies

Management of Severe Hypersensitivity Reaction and Serum Sickness in a Case of Aplastic Anemia: Case Report Using Tocilizumab

David C. Sabatino, PharmD, BCOP; Alina Varabyeva, PharmD, BCOP; Joseph Jurcic, MD

Online First

Case Reports, Breast Cancer, Chemotherapy

Highly Effective Treatment for Bone-Only Signet Ring Cell Breast Cancer With Ribociclib, Fulvestrant, and Denosumab: A Case Study

Marjorie Ford Nenadich, PharmD, BS; Michelle Faith Nenadich, BSN; Basel Shoua, MD

Voices From ASCO 2025

Revolutionizing Cancer Care: Dr. Enrique Velazquez Villarreal on AI-HOPE and the Future of Oncology